Search

Displaying results 7821 - 7830 of 10000 in total
  1. Drug

    Vilzemetkib

    go.drugbank.com/drugs/DB21704
    Experimental

    Vilzemetkib is a small molecule drug. The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor. … Vilzemetkib has a monoisotopic molecular weight of 642.27 Da.

  2. Drug

    Dicirenone

    go.drugbank.com/drugs/DB20938
    Experimental

    Dicirenone is a small molecule drug. The usage of the INN stem '-renone' in the name indicates that Dicirenone is a mineralocorticoid receptor (MR, MCR, aldosterone receptor) antagonist. … Dicirenone has a monoisotopic molecular weight of 428.26 Da.

  3. Drug

    Elmustine

    go.drugbank.com/drugs/DB20979
    Experimental

    Elmustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Elmustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative. … Elmustine has a monoisotopic molecular weight of 195.04 Da.

  4. Drug

    Abitesartan

    go.drugbank.com/drugs/DB19863
    Experimental

    Abitesartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Abitesartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic). … Abitesartan has a monoisotopic molecular weight of 461.24 Da.

  5. Drug

    Mindoperone

    go.drugbank.com/drugs/DB20001
    Experimental

    Mindoperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Mindoperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative. … Mindoperone has a monoisotopic molecular weight of 408.22 Da.

  6. Drug

    Timiperone

    go.drugbank.com/drugs/DB20070
    Experimental

    Timiperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Timiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative. … Timiperone has a monoisotopic molecular weight of 397.16 Da.

  7. Drug

    Candoxatrilat

    go.drugbank.com/drugs/DB11623
    Experimental

    A potent inhibitor of neutral endopeptidase (NEP, neprilysin, EC 3.4.24.11), it is used as its 2,3-dihydro-1H-inden-5-yl ester prodrug in the treatment of chronic heart failure. … A dicarboxylic acid monoamide obtained by formal condensation between the amino group of cis-4-aminocyclohexanecarboxylic acid and the cyclopentanecarboxylic acid group of 1-[(2S)-2-carboxy-3-(2-methoxyethoxy

  8. Drug

    TAS-102

    go.drugbank.com/drugs/DB08937
    Investigational

    TAS-102 (Taiho Pharma USA, Inc.) is an anti-cancer drug under development and in stage 3 clinical trials for the treatment of colorectal cancer.

  9. Drug

    Basic Fibroblast Growth Factor

    go.drugbank.com/drugs/DB14131
    Investigational

    Although it is not approved for use in Canada or the USA, bFGF is currently undergoing investigation in a number of clinical trials. … The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages.

  10. Drug

    R-30490

    go.drugbank.com/drugs/DB09179
    Experimental

    R-30490 is an opioid related to carfentanil used as an animal tranquilizer. … It was first synthesized by Janssen Pharmaceutica as part of a structure-activity relationship study of fentanly and its derivatives.